Publications by authors named "Silke Lassmann"

Claim this Profile
C
Comprehensive molecular profiling of urologic tumors presented in a molecular tumor board: insights from a real-world precision oncology cohort.
Maximilian Glienke, Ruth Himmelsbach, Max Zirngibl, Patrick Metzger, Julia Kühn, Silke Lassmann

Front Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to PD-1 inhibition in MMRd/MSS pancreatic ductal adenocarcinoma: the relevance of parallel testing.
Heike L Pahl, Silke Lassmann, Anne M Schultheis, Stephan Rau, Melanie Börries

J Cancer Res Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infantile myofibromatosis and capillary malformation of the skin due to PDGFRB mosaicism.
Luise Pudig, Silke Lassmann, Sebastian Jacob, Marina Nastainczyk-Wulf, Anja Haak

Mol Cell Pediatr· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity.
Lukas M Braun, Sophie Giesler, Geoffroy Andrieux, Roxane Riemer, Nana Talvard-Balland, Silke Lassmann

Cancer Cell· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmarking whole exome sequencing in the German network for personalized medicine.
Michael Menzel, Mihaela Martis-Thiele, Hannah Goldschmid, Alexander Ott, Eva Romanovsky, Silke Lassmann

Eur J Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Results of Patients with Genitourinary Malignancies Presented at a Molecular Tumor Board.
Jakob Michaelis, Ruth Himmelsbach, Patrick Metzger, Silke Lassmann, Melanie Börries

Urol Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors.
Julia C Kuehn, Patrick Metzger, Nicolas Neidert, Uta Matysiak, Linda Gräßel, Silke Lassmann

NPJ Precis Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters.
Michaela A Ihle, Carina Heydt, Anne Maria Schultheis, Robert Stöhr, Florian Haller

Sci Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer.
Philip Bischoff, Martin Reck, Tobias Overbeck, Petros Christopoulos, Achim Rittmeyer, Silke Lassmann

J Thorac Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing CD3 diversity to optimize CAR T cells.
Rubí M-H Velasco Cárdenas, Simon M Brandl, Ana Valeria Meléndez, Alexandra Emilia Schlaak, Annabelle Buschky, Silke Lassmann

Nat Immunol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients.
Michael Menzel, Stephan Ossowski, Sebastian Kral, Patrick Metzger, Peter Horak, Silke Lassmann

NPJ Precis Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[RET in molecular pathology of sporadic solid tumors].
Silke Laßmann

Pathologie (Heidelb)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Report of the Molecular Pathology Working Group : 105th annual meeting of the German Society for Pathology].
Udo Siebolts, Silke Laßmann, Nicole Pfarr

Pathologie (Heidelb)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a DNA-Based Next-Generation Sequencing Test for Molecular Diagnostic Variant and Fusion Detection in Formalin-Fixed, Paraffin-Embedded Tissue Specimens and Liquid Biopsy Plasma/Cell-Free DNA Samples.
Tamara V Werner, Sylvia Kock, Isabel Weber, Gian Kayser, Martin Werner, Silke Lassmann

J Mol Diagn· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Detection of BRAF V600E mutation in metastatic colorectal carcinoma : A QuIP round robin test].
Korinna Jöhrens, Josephine Fischer, Markus Möbs, Klaus Junker, Jutta Kirfel

Pathologe· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer.
Silvia Waldeck, Jan Mitschke, Sebastian Wiesemann, Michael Rassner, Geoffroy Andrieux, Silke Lassmann

Mol Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Report of the Molecular Pathology Working Group: Virtual Pathology Days of the DGP].
Silke Laßmann, Florian Haller, Udo Siebolts

Pathologe· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations.
Felix C Saalfeld, Carina Wenzel, Petros Christopoulos, Sabine Merkelbach-Bruse, Timm M Reissig

J Thorac Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Molecular tumor boards - insights and perspectives].
Silke Laßmann, Michael Hummel

Pathologe· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating quantitative proteomics with accurate genome profiling of transcription factors by greenCUT&RUN.
Sheikh Nizamuddin, Stefanie Koidl, Tanja Bhuiyan, Tamara V Werner, Martin L Biniossek, Silke Lassmann

Nucleic Acids Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis.
Rouven Hoefflin, Adriana Lazarou, Maria Elena Hess, Meike Reiser, Julius Wehrle, Silke Lassmann

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variant classification in precision oncology.
Jonas Leichsenring, Peter Horak, Simon Kreutzfeldt, Christoph Heining, Petros Christopoulos, Silke Lassmann

Int J Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases.
Martin Roatsch, Inga Hoffmann, Martine I Abboud, Rebecca L Hancock, Hanna Tarhonskaya, Silke Lassmann

ACS Chem Biol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical management of lower-grade glioma in the spotlight of the 2016 WHO classification system.
Daniel Delev, Dieter Henrik Heiland, Pamela Franco, Peter Reinacher, Irina Mader, Silke Lassmann

J Neurooncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center Experience.
Rouven Hoefflin, Anna-Lena Geißler, Ralph Fritsch, Rainer Claus, Julius Wehrle, Silke Lassmann

JCO Precis Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis